References
- Hurlen M, Abdelnoor M, Smith P, Erikssen J, Arnesen H. Warfarin, aspirin, or both after myocardial infarction. N. Engl. J. Med.347(13), 969–974 (2002).
- Stone WG, McLaurin BT, Cox DA et al.; ACUITY investigators. Bivalirudin for patients with acute coronary syndromes. N. Engl. J. Med.355(21), 2203–2216 (2006).
- Connolly SJ, Ezekowitz MD, Yusuf S et al.; RE-LY steering committee and investigators. Dabigatran versus warfarin in patients with atrial fibrillation. N. Engl. J. Med.361(12), 1139–1151 (2009).
- Wallentin L, Becker RC, Budaj A et al.; PLATO investigators. Ticagrelor versus clopidogrel in patients with acute coronary syndromes. N. Engl. J. Med.361(11), 1045–1057 (2009).
- Wiviott SD, Braunwald E, McCabe CH et al.; TRITON-TIMI 38 investigators. Prasugrel versus clopidogrel in patients with acute coronary syndromes. N. Engl. J. Med.357(20), 2001–2015 (2007).
- Kuliczkowski W, Witkowski A, Watala C et al. Resistance to oral antiplatelet drugs – a position paper of the Working Group on Antiplatelet Drug Resistance appointed by the Section of Cardiovascular Interventions of the Polish Cardiac Society. Eur. Heart J.66(4), 470–476, 480–485 (2009).
- Pettersen AÅ, Seljeflot I, Abdelnoor M et al. Unstable angina, stroke, myocradial infarction and death in aspirin non-responders. A prospective, randomised trial (ASCET). The ASCET (Aspirin Non-Responsiveness and Clopidogrel Endpoint Trial) design. Scand. Cardiovasc. J.38(6), 353–356 (2004).
- Knudsen EC, Seljeflot I, Abdelnoor M et al. Abnormal glucose regulation in patients with acute ST-elevation myocardial infarction – a cohort study on 224 patients. Cardiovasc. Diabetol.8, 6 (2009).
- Bøhmer E, Hoffmann P, Abdelnoor M, Arnesen H, Halvorsen S. Efficacy and safety of immediate angioplasty versus ischemia-guided management after thrombolysis in acute myocardial infarction in areas with very long transfer distances results of the NORDISTEMI (Norwegian Study on District treatment of ST-Elevation Myocardial Infarction). J. Am. Coll. Cardiol.55(2), 102–110 (2009).
- Tveit A, Seljeflot I, Grundvold I, Abdelnoor M, Smith P, Arnesen H. Levels of PAI-1 and outcome after electrical cardioversion for atrial fibrillation. Thrombos. Res.121(4), 447–453 (2008).